share_log
Benzinga ·  Mar 11 20:33
Geron Corporation Announces That The European Commission Has Granted Marketing Authorization For Rytelo As A Monotherapy For The Treatment Of Adult Patients With Transfusion-Dependent Anemia
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
1
Comment Comment · Views 243

Recommended

Write a comment